Article | May 6, 2024

Translating Study Reports – A GLP Draft Guidance

Source: CAI

By LeAnna Pearson, Associate Director, QCR

GettyImages-1302454470 drug review

The FDA has published a guide has been created for the translation of studies conducted by non-US testing facilities. The studies, which fall under Good Laboratory Practices, are expected to be translated from the facility's native language to English. The translation must be clear, accurate, complete, truthful, and follow written processes. The translated report should include a statement of certification requirements and sections such as the cover page, summary, materials and methods, results, discussion, conclusions, and appendices. The translator should have training in English and experience in native language translations, especially with medical and scientific documents. The sponsor or testing facility should have written procedures for the translation of studies and retain all related documents. Any amendment to the original final report should be translated separately.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Pharmaceutical Online